Xenetic Biosciences, Inc.
XBIO· Nasdaq
XBIOXenetic Biosciences, Inc.
Filed Aug 14, 2017 · 10-Q · 45 days after period end · 0001683168-17-002122
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$2.92M | -$47.77M | -$1.13M | -$2.76M |
| EPS Diluted | -$0.34 | -$6.12 | -$0.27 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end
